SNO 2020: Lapatinib + WBRT/SRS Trends Toward Improvement of Brain Metastases From HER2+ Breast Cancer
The drug crosses the blood-brain barrier and demonstrates activity against brain metastases.
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.